Standard Biotools (LAB) Acquisitions (2014 - 2024)
Standard Biotools (LAB) posted quarterly Acquisitions of -$278.6 million for Q4 2024, down 199.51% quarter-over-quarter from $280.0 million in Q1 2024.
Standard Biotools (LAB) Acquisitions (2014 - 2024) Analysis & Trends
Standard Biotools (LAB) has reported Acquisitions for 3 consecutive years, with -$278.6 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Acquisitions changed N/A year-over-year to -$278.6 million; the TTM figure through Sep 2025 stood at -$278.6 million (down 199.51% YoY), while the FY2024 annual figure was $1.4 million, changed N/A from the prior year.
- Acquisitions slipped to -$278.6 million in Q4 2024 per LAB's latest filing, from $280.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $280.0 million in Q1 2024 and bottomed at -$278.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.09 Bn | 122.62 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 118.39 Bn | 109.17 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 72.77 Bn | 72.24 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.04 Bn | 47.78 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.42 Bn | 32.47 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.65 Bn | 31.54 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.29 Bn | 22.97 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.06 Bn | 22.57 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Standard Biotools | 249.58 Mn | -227.14 Mn | 10.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -278.65 Mn |
| Mar 31, 2024 | 280.03 Mn |
| Mar 31, 2020 | 5.15 Mn |
| Mar 31, 2014 | 113.19 Mn |